Pipeline | Indication | Efficacy | Pre-Clinical | Phase 1 | Phase 2 | Phase 3 |
---|---|---|---|---|---|---|
NovDB2 | Diabetes |
|
||||
NovOB | Obesity |
|
||||
NovRD | Chronic Kidney Disease |
|
||||
NovFS | Fibrosis |
|
||||
NovRF | Peritoneal Fibrosis |
|